Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.2550 (1.19%) ($7.2550 - $7.2550) on Fri. Sep. 1, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.11% (three month average) | RSI | 54 | Latest Price | $7.2550(1.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.3% a day on average for past five trading days. | Weekly Trend | BCRX advances 0.7% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) UNG(48%) USO(32%) XOP(30%) XLE(29%) VIXM(23%) | Factors Impacting BCRX price | BCRX will decline at least -1.555% in a week (0% probabilities). ARKK(-56%) XLRE(-42%) EWI(-41%) DIA(-41%) BLOK(-40%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.555% (StdDev 3.11%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.15(1.47%) | 10 Day Moving Average | $7.2(0.76%) | 20 Day Moving Average | $7.1(2.18%) | To recent high | -18.1% | To recent low | 8.3% | Market Cap | $1.28b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |